首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   740篇
  免费   51篇
  国内免费   4篇
耳鼻咽喉   9篇
儿科学   16篇
妇产科学   40篇
基础医学   135篇
口腔科学   12篇
临床医学   60篇
内科学   131篇
皮肤病学   6篇
神经病学   41篇
特种医学   9篇
外科学   116篇
综合类   7篇
预防医学   26篇
眼科学   10篇
药学   28篇
肿瘤学   149篇
  2023年   3篇
  2022年   11篇
  2021年   11篇
  2020年   6篇
  2019年   26篇
  2018年   23篇
  2017年   32篇
  2016年   24篇
  2015年   26篇
  2014年   28篇
  2013年   35篇
  2012年   57篇
  2011年   49篇
  2010年   41篇
  2009年   18篇
  2008年   55篇
  2007年   70篇
  2006年   68篇
  2005年   76篇
  2004年   50篇
  2003年   20篇
  2002年   21篇
  2001年   5篇
  2000年   5篇
  1999年   2篇
  1998年   2篇
  1997年   1篇
  1996年   2篇
  1993年   1篇
  1992年   3篇
  1991年   2篇
  1990年   2篇
  1989年   1篇
  1988年   3篇
  1987年   1篇
  1986年   1篇
  1981年   1篇
  1979年   1篇
  1975年   4篇
  1974年   1篇
  1973年   3篇
  1972年   1篇
  1969年   1篇
  1966年   1篇
  1965年   1篇
排序方式: 共有795条查询结果,搜索用时 662 毫秒
101.
Craniopharyngioma is a benign tumour that needs total resection to reduce the recurrence rate and consequently improve the quality of life for the affected children. As this tumour is closely related to the optic nerves, chiasm and hypothalamus, total removal cannot be achieved without difficulty. It has been reported that total resection could be achieved in up to 75% of the patients by microsurgical techniques. In this study we aimed to improve the total resection rate by adding endoscopy to the microsurgical instrumentation. This has improved the total resection rate by nearly 10%.  相似文献   
102.
103.
104.
We evaluated the effects of pentoxifylline (PTX) and alpha-tocopherol on the clinical outcome of 66 patients with stage IIIB non-small cell lung cancer in a randomized clinical trial. All patients received 46 Gy of external radiotherapy to the primary tumor and regional lymph, nodes with an additional 14-Gy dose to the primary tumor. Thirty-three of the 66 patients also received PTX (400 mg, three times daily) and alpha-tocopherol (300 mg, twide daily) during radiotherapy, followed by 400 mg of PTX and 300 mg of alpha-tocopherol daily for 3 mo after radiotherapy. The remaining 33 patients (control group) received radiotherapy only. After a mean follow-up time of 12 mo, 18 patients remained alive. During follow-up, there were local recurrences in 14 patients and distant metastases in 18 patients. In patients who received PXT and alpha-tocopherol, 1- and 2-yr overall survival rates were 55% and 30%, respectively, and median survival was 18 mo. In control patients, 1- and 2-yr overall survival rates were 40% and 14%, respectively, with a median survival of 10 mo. These differences were statistically significant (p=0.0175). In patients who received PXT and alpha-tocopherol, progression-free survival rates for 1 and 2 yr were 48% and 23%, respectively; median survival was 12 mo. In the control group, the corresponding rates were 24% and 18%; median survival was 8 mo (p=0.0223). We conclude that the use of PTX and alpha-tocopherol combined with radiotherapy offers a possible survival advantage in this patient population.  相似文献   
105.
In this paper we have investigated the kinetic decomposition of 2-chloroethylnitrososulfamides (CENS) in fetal calf serum. The study was monitored by on-line solid phase extraction linked to RP-LC-MS. We demonstrated that CENS are less stable in fetal calf serum than in aqueous buffer at pH 7.4 and 37 degrees C. Moreover, we have shown that partition coefficient of CENS can be correlated to the kinetics decomposition, and we observe that the stability is better for lipophilic CENS. The different metabolites after decomposition have been tentatively identified by RP-HPLC-MS. This study indicates the formation of several metabolites resulting from a mechanism of decomposition more complex than in aqueous phosphate buffer, nevertheless, leading to the same main products.  相似文献   
106.
The aim of this study was to describe vaginal douching practices among women of reproductive age in Turkey, and to examine the association between this practice and adverse reproductive health consequences. Of the 524 participants, 58% reported vaginal douching at some time in their lives. The practice is primarily used for hygienic reasons and a majority used water alone and homemade solution. Using a multivariate model, only age (P = 0.05) and intrauterine device usage (P = 0.02) were associated with vaginal douching.  相似文献   
107.
Von Hippel-Lindau Disease, a multisystem familial cancer syndrome, is inherited as an autosomal-dominant trait. Common manifestations of the disease are retinal, cerebellar and medullary hemangioblastomas; renal cysts and carcinomas; pancreatic cysts; pheochromocytoma; and papilllary cystadenoma of the epididym. We report the case of a 40-year-old man with type I von Hippel-Lindau disease treated with external radiotherapy for recurrent cerebellar hemangioblastoma.  相似文献   
108.
109.
Synovial sarcoma usually arises in the extremities and in close proximity to large joints. Primary synovial sarcoma of the anterior abdominal wall is rare. A 17-year-old girl was admitted to the hospital with a palpable abdominal mass, and there was a 9.5 cm x 7.5 cm x 6-cm lobulated, cystic, and semisolid lesion of in the external oblique abdominal muscle shown on the abdominal magnetic resonance image. She was then operated and pathology was consistent with synovial sarcoma. The presence of synovial sarcoma in extraarticular sites such as the abdominal wall argues against an origin from arthrogenous mesenchyme.  相似文献   
110.
Advances in molecular biology have identified tumor markers that not only predict prognosis and therapeutic response but may also function as potential therapeutic targets. Activated growth factor receptors induce breast cancer cells to proliferate, invade, and metastasize in experimental models. Overexpression of growth factor receptors has been associated with a poor clinical outcome in breast cancer patients. Biological therapy with monoclonal antibody directed against growth factor receptor pathways became important targeted therapy in breast cancer and is being pursued on various fronts. The anti-HER2 antibody trastuzumab is approved in the metastatic setting and is now trying to find the place in the adjuvant setting. Phase II and III studies with antibodies directed against VEGF and EGFR are also ongoing.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号